HAEMALOGIX PTY LTD has a total of 29 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are LEUKOTECH AS, UBIPROTEIN CORP and AGENUS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Hong Kong | 2 | |
#8 | Republic of Korea | 2 | |
#9 | United States | 2 | |
#10 | Israel | 1 | |
#11 | Japan | 1 | |
#12 | Russian Federation | 1 | |
#13 | Singapore | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Dunn Rosanne | 20 |
#2 | Micklethwaite Kenneth | 11 |
#3 | Gottlieb David | 10 |
#4 | Logan Grant | 10 |
#5 | Raison Robert Lindsay | 4 |
#6 | Dunn Rosanne Dorothy | 4 |
#7 | Rosanne Dunn | 3 |
#8 | Jones Darren Ross | 3 |
#9 | Hutchinson Andrew Tasman | 3 |
#10 | Asvadi Parisa | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020113263A1 | Method of treatment | |
CN111918879A | anti-Lambda Myeloma Antigen (LMA) binding proteins for the treatment of LMA expressing cancers and autoimmune diseases | |
WO2019108932A1 | Methods for expanding kappa myeloma antigen chimeric antigen receptors expressing cells | |
EP3286223A2 | Kappa myeloma antigen chimeric antigen receptors and uses thereof | |
AU2005216575A1 | Target for B-cell disorders | |
AU2002344701B2 | Method for treating multiple myeloma |